About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in North Carolina | 84 Studies

Clinical Trials Ovarian CancerNorth Carolina

Ovarian Cancer Clinical Trials in North Carolina

Find 84 clinical trials for ovarian cancer near North Carolina. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in North Carolina

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 84 trials

Active not recruitingNational Cancer Institute "Cancer Moonshot Biobank"This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study.NCT04314401·Daphne, Alabama and 149 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingMultimedia Aid for Genetic Testing in Gynecologic OncologyThis pilot study aims to estimate rates of genetic testing in patients with ovarian and endometrial cancer before and after the implementation of educational videos about genetic…NCT07084168·Chapel Hill, North Carolina

TerminatedChemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00002819·Birmingham, Alabama and 63 others

CompletedPhase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic MalignanciesThe purpose of this study is to determine the safety, tolerability, and efficacy of INCAGN01876 when given in combination with immune therapies in subjects with advanced or…NCT03126110·Los Angeles, California and 37 others

RecruitingcfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseThis is an observational case-control study to train and validate a genome-wide methylome enrichment platform to detect multiple cancer types and to differentiate amongst cancer…NCT05366881·Duarte, California and 16 others

TerminatedVaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial CancerRATIONALE: Vaccines made from tumor tissue may make the body build an immune response and kill tumor cells.NCT00003386·Birmingham, Alabama and 59 others

Terminated(VELA) Study of BLU-222 in Advanced Solid TumorsThis is a Phase 1/2, open-label, first-in-human (FIH) study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and anticancer activity of…NCT05252416·Little Rock, Arkansas and 22 others

RecruitingReal World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom MonitoringThe goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system…NCT05974150·New Haven, Connecticut and 6 others

Active not recruitingStudy of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)The purpose of this study is to find out whether the study drug, LY3537982, is safe and effective in cancer patients who have a specific genetic mutation (KRAS G12C).NCT04956640·Birmingham, Alabama and 48 others

TerminatedLiposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00003380·Birmingham, Alabama and 62 others

TerminatedPhase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian CancerThe purpose of this research study is to determine if Telcyta® given in combination with liposomal doxorubicin is more effective than liposomal doxorubicin alone in treating women…NCT00350948·Casa Grande, Arizona and 70 others

TerminatedOpen-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesThe purpose of the Study is to select a dose and assess the safety and tolerability of INCB057643 as a monotherapy (Part 1 and Part 2) and in combination with standard-of-care…NCT02711137·Birmingham, Alabama and 17 others

CompletedAssess Cancer in Ovarian Tumors With Biomarkers.Purpose The OvaRI assay clinical trial is directed at evaluating a novel proteomics-based blood test.NCT00436189·Hoover, Alabama and 17 others

CompletedTopotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy, such as topotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00114166·Hartford, Connecticut and 77 others

CompletedTemsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian CancerThis phase II trial studies how well temsirolimus, carboplatin, and paclitaxel as first-line therapy works in treating patients with newly diagnosed stage III-IV clear cell…NCT01196429·Phoenix, Arizona and 144 others

UnknownPaclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube CancerThis randomized phase III trial studies paclitaxel to see how well it works compared to polyglutamate paclitaxel or observation only in treating patients with stage III or stage…NCT00108745·Birmingham, Alabama and 314 others

CompletedA Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid TumorsProtocol B8011001 is a Phase 1, open-label, multi-center, multiple-dose, dose escalation and expansion, safety, pharmacokinetics (PK), and pharmacodynamics (PD) study of…NCT02573259·Los Angeles, California and 66 others

TerminatedTopotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00005029·Birmingham, Alabama and 73 others

CompletedBupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic CancerThis phase II randomized trial studies how well bupropion hydrochloride works in improving sexual desire in women with breast or gynecological cancer.NCT03180294·Anaheim, California and 361 others

CompletedCombination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00002568·Birmingham, Alabama and 54 others

PreviousPage 3 of 5Next

Other Conditions in North Carolina

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia